Vytrus Biotech, S.A. (BME:VYT)

Vytrus Biotech Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.38	2.53	1.1	0.72	1.28
Short-Term Investments	0.06	0	0	-	0
Cash & Short-Term Investments	3.44	2.53	1.11	0.72	1.28
Cash Growth	36.01%	128.81%	52.54%	-43.56%	17.37%
Accounts Receivable	0.98	0.62	0.55	0.44	0.21
Other Receivables	0.33	0.11	0.23	0.09	0.05
Receivables	1.31	0.73	0.78	0.53	0.27
Inventory	0.64	0.54	0.56	0.43	0.26
Other Current Assets	-	-	-	-	0.01
Total Current Assets	5.39	3.79	2.45	1.68	1.82
Property, Plant & Equipment	1.67	0.86	0.93	1.03	0.68
Long-Term Investments	0.1	0.09	0.09	0.07	0.04
Other Intangible Assets	4.96	4.08	3.63	3.15	2.84
Long-Term Deferred Tax Assets	2.53	2.32	2.22	2.07	1.81
Other Long-Term Assets	0.01	-	-	-	-
Total Assets	14.66	11.13	9.31	8	7.18

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.05	0.1	0.04	0.17	0.16
Accrued Expenses	0.45	0.38	0.07	0.17	0.16
Current Portion of Long-Term Debt	0.36	0.38	0.34	0.25	0.19
Current Income Taxes Payable	0.05	-	-	-	-
Other Current Liabilities	0.87	0.4	0.54	0.68	0.29
Total Current Liabilities	1.78	1.25	1	1.27	0.81
Long-Term Debt	0.88	1.39	1.73	0.74	0.74
Long-Term Deferred Tax Liabilities	1.03	0.59	0.66	0.69	0.59
Other Long-Term Liabilities	0.66	0.6	0.63	0.55	0.8
Total Liabilities	4.35	3.84	4.02	3.25	2.93

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.08	0.08	0.07	0.07	0.07
Additional Paid-In Capital	4.63	4.63	3.4	3.4	3.4
Retained Earnings	3.43	1.32	1.45	1.21	0.7
Treasury Stock	-0.52	-0.28	-0.9	-0.59	-0.23
Comprehensive Income & Other	2.69	1.55	1.26	0.66	0.31
Shareholders' Equity	10.31	7.29	5.29	4.75	4.25
Total Liabilities & Equity	14.66	11.13	9.31	8	7.18

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.24	1.77	2.08	0.98	0.93
Net Cash (Debt)	2.2	0.76	-0.97	-0.26	0.35
Net Cash Growth	190.78%	-	-	-	57.68%
Net Cash Per Share	0.29	0.10	-0.14	-	0.05
Filing Date Shares Outstanding	7.52	7.52	6.74	-	6.93
Total Common Shares Outstanding	7.52	7.52	6.74	-	6.93
Working Capital	3.61	2.54	1.46	0.41	1.01
Book Value Per Share	1.37	0.97	0.79	-	0.61
Tangible Book Value	5.35	3.22	1.66	1.6	1.42
Tangible Book Value Per Share	0.71	0.43	0.25	-	0.20
Buildings	0.03	0.02	0.02	0.02	0.02
Machinery	2.28	1.37	1.28	1.34	0.88

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error